Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: Determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC)

Journal of Immunological Methods

Volumn 214, Issue 1-2, 1998, Pages 121-129

  Cohard, Marielle ^a   Liu, Qingyan ^a   Perkus, Marion ^b   Gordon, Ethel ^a   Brotman, Betsy ^a   Prince, Alfred M ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b Virogenetics Inc   (United States)

Author keywords

Canarypox virus; CTL precursor frequency; HCV CTL response

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; CELL KILLING; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC LYMPHOCYTE; HEPATITIS C; HEPATITIS C VIRUS; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; CANARYPOX VIRUS; HEPATITIS C VIRUS; MAMMALIA; MIRIDAE; PAN (APE); PAN TROGLODYTES;

EID: 0031865707     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00054-4     Document Type: Article

References (29)

1. Alter M.J., Margolis H.S., Krawczynski K., Judson F., Mares A., Alexander W., Hu P.Y., Miller J.K., Gerber M.A., Sampliner R.E. The natural history of community-acquired hepatitis C in the United States. New Engl. J. Med. 327:1992;1899.
2. Battegay M., Fikes J., Dibisceglie A.M., Wentworth P.A., Sette A., Celis E., Ching W.M., Grakoui A., Rice C.M., Kurokohchi K., Berzofsky J.A., Hoofnagle J.H., Feinstone S.M., Akatsuka T. Patients with chronic hepatitis C have circulating cytotoxic cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:1996;2462.
3. Botarelli P., Brunetto M.R., Minutello M.A., Calvo P., Unutmaz D., Weiner A.J., Choo Q.L., Shuster J.R., Kuo G., Bonino F. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580.
4. Brotman B., Prince A.M., Huima T. Non-A, Non-B hepatitis: is there more than a single blood-borne strain. J. Infect. Dis. 151:1985;618.
5. Cerny A., Chisari F.V. Immunological aspects of HIV infection. Intervirology. 37:1994;119.
6. Cerny A., McHutchison J.G., Pasquinelli C., Brown M.E., Brothers M.A., Grabscheld B., Fowler P., Houghton M., Chisari F.V. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Invest. 95:1995;521.
7. Cox W.I., Tartaglia J., Paoletti E. Induction of Cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology. 195:1993;845.
8. Cuthbert J.A. Hepatitis C: progress and problems. Clin. Microbiol. Rev. 7:1994;505.
9. Erickson A.L., Houghton M., Choo Q.L., Weiner A.J., Ralston R., Muchmore E., Walker C.M. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C. J. Immunol. 151:1993;4189.
10. Gillard S., Spehner D., Drillien R., Kirn A. Localization and sequence of a vaccinia virus gene required for multiplication in human cells. Proc. Natl. Acad. Sci. U.S.A. 83:1986;5573.
11. Kita H., Moriyama T., Kanako T., Harase L., Nomura M., Miura H., Nakamura L., Yazaki Y., Imawari M. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 18:1993;1039.
12. Koziel M.J., Dudley D., Wong J., Dienstag J., Houghton M., Ralston R., Walker B.D. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 149:1992;3339.
13. Koziel M.J., Dudley D., Afdhal N., Choo Q.L., Houghton M., Ralston R., Walker B. Hepatitis C virus-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:1993;7522.
14. Lai J.P., Prince A.M., Wolfe L.L., Andrus L. A simplified method for PCR detection of hepatitis C virus RNA from human serum. PCR Methods Apll. 3:1994;308.
15. Lubaki M.N., Egan M.A., Silicano R.F., Weinhold K.K., Bollinger R.C. A novel method for detection and ex vivo expansion of HIV type 1-specific cytotoxic T lymphocytes. AIDS Res. Hum. Retroviruses. 11:1994;1427.
16. Minutello M.A., Pileri P., Unutmaz D., Censini S., Kuo G., Houghton M., Brunetto M.R., Bonino F., Abrignani S. Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J. Exp. Med. 178:1993;17.
17. Mondelli M., Manns M., Ferrari C. Does the immune response play a role in the pathogenesis of chronic liver disease. Arch. Pathol. Lab. Med. 112:1988;489.
18. Neitzel H. A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet. 73:1986;320.
19. Panicali D., Davis S.W., Mercer S.R., Paoletti E. Two major DNA variants present in serially propagated stocks of the WR strain of vaccinia virus. J. Virol. 37:1981;1000.
20. Perkus M.E., Limbach K., Paoletti E. Cloning and expression of foreign genes in vaccinia virus, using a host range selection system. J. Virol. 63:1989;3829.
21. Perkus M.E., Kauffman E.B., Taylor J., Mercer S., Smith D., VanderHoeven J., Paoletti E. Methodology of using vaccinia virus to express foreign genes in tissue culture. J. Tis. Cult. Meth. 15:1993;72.
22. Prince A.M., Stephan W., Dichtelmüller H., Brotman B., Huima T. Inactivation of the Hutchinson Strain of Non-A, Non-B hepatitis virus by combined use of β-propiolactone and ultraviolet irradiation. J. Med. Virol. 16:1985;119.
23. Shankar P., Fabry J., Lieberman J. A simple method to selectively expand HIV-specific cytotoxic T lymphocytes in vitro. Immunol. Invest. 24:1995;489.
24. Shimizu Y.K., Hijikata M., Iwamoto A., Alter H.J., Purcell R.H., Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J. Virol. 68:1994;1494.
25. Shirai M., Akatsuka T., Pendleton C.D., Houghten R., Wychowski C., Mihalik K., Feinstone S.M., Berzofsky J.A. Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. J. Virol. 66:1992;4098.
26. Shirai M., Okada H., Nishioka M., Akatsuka T., Wychowski C., Houghten R., Pendleton C.D., Feinstone S.M., Berzofsky J.A. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J. Virol. 68:1994;3334.
27. Tartaglia J., Perkus M.E., Taylor J., Norton E.K., Audonnet J.C., Cox W.I., David S.W., VanderHoeven J., Meignier B., Riviere M., Languet B., Paoletti E. NYVAC: a highly attenuated strain of vaccinia virus. Virology. 188:1992;217.
28. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. Validity tests for the Single-Hit Poisson Model. J. Immunol. Methods. 72:1984;29.
29. Walker C.M. Cytotoxic T-lymphocyte responses to the hepatitis C virus in humans and chimpanzees. Sem. Virology. 7:1996;13.